MEDPLUS.BOMEDPLUS.BO
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +11.90% | +8.32% | +1.28% | +3.61% | +6.54% |
| Gross Profit Growth | +22.93% | +22.63% | +18.37% | +22.37% | -58.00% |
| EBITDA Growth | +78.16% | +88.54% | +36.97% | +66.33% | +104.88% |
| Operating Income Growth | +32.22% | +26.37% | +24.32% | +20.92% | -58.61% |
| Net Income Growth | +165.97% | +234.30% | +53.72% | +194.91% | +43.28% |
| EPS Growth | +165.57% | +233.91% | +53.74% | +195.00% | +42.90% |
| EPS Diluted Growth | +166.94% | +235.09% | +54.12% | +194.17% | +43.03% |
| Weighted Average Shares Growth | -0.36% | -0.24% | -0.34% | +0.25% | -0.09% |
| Weighted Average Shares Diluted Growth | -0.36% | -0.24% | -0.26% | +0.25% | +0.17% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -100.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -100.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +103.54% | +0.00% | -24.18% | +0.00% | +0.63% |
| Inventory Growth | +5.16% | -100.00% | +0.36% | +0.00% | -4.47% |
| Asset Growth | +7.41% | -100.00% | +11.82% | +0.00% | +13.22% |
| Book Value per Share Growth | +7.85% | +6.06% | +10.68% | +10.03% | +12.85% |
| Debt Growth | +7.48% | +0.00% | +10.92% | +0.00% | +15.86% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +14.29% | +18.90% | +14.15% | +23.87% | -57.35% |